UAE's Genetic Research Uncovers 100 Causes of Inherited Eye Disorders

M42 has unveiled the outcomes of an extensive national study in collaboration with the Department of Health – Abu Dhabi, showcasing the potential of genomics in the early detection and prevention of inherited eye disorders.

The research identified approximately 100 genetic origins of vision impairment within the Emirati demographic. This crucial finding aids in understanding genetic factors affecting eye health and paves the way for more precise early interventions.

Scientists examined genomic data from over 500,000 Emirati citizens participating in the Emirati Genome Programme, which is overseen by the Emirates Genome Council with support from various national entities. This initiative supplies an extensive database that enhances preventive healthcare on a broader scale.

This accomplishment reflects Abu Dhabi's shift towards a healthcare model prioritizing prevention and early identification rather than post-disease treatment. By integrating genetic information with anonymized health records via Malaffi, researchers turned scientific data into practical insights for clinicians and healthcare strategists.

This methodology enables healthcare providers to identify individuals at increased risk of disease before symptoms manifest. It also facilitates early surveillance, genetic counseling, and tailored treatment strategies.

Dr. Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, expressed that the study underscores the emirate's commitment to utilizing advanced science and data to enhance healthcare outcomes. She noted that genomics enables prompt detection, prevention, and superior health policies to uphold public health over time.

Dimitris Moulavasilis, CEO of M42, stated that the findings illustrate how the fusion of genomic insights with real-world health data can foster enhanced preventive measures and more precise healthcare solutions.

The research spotlighted specific genes like ABCA4, associated with inherited retinal conditions such as Stargardt disease, which progressively affects central vision, often beginning in childhood or adolescence.

Additionally, researchers discovered a rare yet treatable genetic disorder that can lead to early vision complications. This emphasizes how comprehensive genomic studies can aid in early diagnostics and targeted therapies. The study also clarified that a higher frequency of a genetic variant does not necessarily equate to an increased risk of disease.

The Emirati Genome Programme stands as one of the largest genomic sequencing initiatives globally, with over 850,000 genomes examined to date. This study further cements Abu Dhabi's role as a frontrunner in health innovation, committed to enhancing quality of life through cutting-edge science.